EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS

類似資料

• Payer coverage policies for multigene tests
  著者:: Phillips, Kathryn A, 等
  出版事項: (2017)
• Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative
  著者:: Trosman, Julia R., 等
  出版事項: (2017)
• Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions
  著者:: Deverka, Patricia A., 等
  出版事項: (2020)
• Challenges of Coverage Policy Development for Next-Generation Tumor Sequencing Panels: Experts and Payers Weigh In
  著者:: Trosman, Julia R., 等
  出版事項: (2015)
• Availability and payer coverage of BRCA1/2 tests and gene panels
  著者:: Clain, Elizabeth, 等
  出版事項: (2015)